Riskpilot← Back to searchSign inGet full accessNeuroShayan AB
ABActiveOrg 5569538134Lilla Varvsgatan 11Physiotherapy activities · NACE 8695Est. 20131 employees
Revenue 2025
SEK 735K
-12% vs 2024
EBITDA margin
1.1%
-11% vs 2024
Equity ratio
19.4%
Financial strength
Net profit 2025
SEK 0
+100% vs 2024
| Revenue | SEK 735K | -12% |
| EBITDA | SEK 8K | -11% |
| Net profit | SEK 0 | +100% |
| Total assets | SEK 191K | +11% |
| Equity | SEK 37K | +0% |
| Employees | 1 | — |
Legal name
NeuroShayan AB
Org number
5569538134
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
12 december 2013
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Sjukgymnastik, arbetsterapi, neuro och smärt-rehabilitering, omskolning och rehabilitering, konsultation genom rådgivning och undervisning samt därmed förenlig verksamhet.
Address
Lilla Varvsgatan 11
Email
amadshayan@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 723 | 889 | 881 | 833 | 735 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −49 | −5 | — | 9 | 8 |
| Depreciation & amort. | −14 | −10 | −0 | −0 | −0 |
| EBIT | −63 | −15 | 0 | 9 | 8 |
| Net financials | −16 | −9 | −17 | −14 | −8 |
| Profit before tax | −78 | −24 | −16 | −4 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −78 | −24 | −16 | −4 | 0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 302 | 206 | 181 | 172 | 191 |
| Equity | 152 | 58 | 42 | 37 | 37 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 150 | 148 | 139 | 135 | 154 |
| Total debt | 150 | 148 | 139 | 135 | 154 |
EBITDA margin
1.1%
This company
15.8%
Market median
-93% vs market
20212025
Equity ratio
19.4%
This company
38.2%
Market median
-49% vs market
20212025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212025
Asset turnover
3.85×
This company
1.12×
Market median
+244% vs market
20212025
Debt / equity
4.16×
This company
0.62×
Market median
-571% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NeuroShayan AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ahmad Shayan | Board of Directors | 0 companies |
| Rana Moghaddam | Deputy Board Member | 0 companies |